Fijneman and colleagues found a set of RUNX1 target genes in mouse colon indicative of changes in gut homeostasis, that is, genes involved in inflammation and intestinal metabolism, which are known to increase the risk of tumor development [57]. The gene discussed is RUNX1; the disease is neoplasm.